CLINICAL_TRIALS
trial_result
· 2011-05-19
Clinical Trial Update: AZD7325 Proof of Concept in Patients With Generalized Anxiety Disorder (GAD) [Phase 2]
Summary
A Phase 2 proof-of-concept trial of AZD7325 in generalized anxiety disorder has completed, with results posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Anxiety Disorders | Phase 2 | Status: COMPLETED | Results posted: 2011-05-19